Author:
Lindeman Neal I.,Cagle Philip T.,Beasley Mary Beth,Chitale Dhananjay Arun,Dacic Sanja,Giaccone Giuseppe,Jenkins Robert Brian,Kwiatkowski David J.,Saldivar Juan-Sebastian,Squire Jeremy,Thunnissen Erik,Ladanyi Marc
Subject
Pulmonary and Respiratory Medicine,Oncology
Reference318 articles.
1. Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer;Miller;J Clin Oncol,2004
2. Biological and clinical features in predicting efficacy of epidermal growth factor receptor tyrosine kinase inhibitors: a systematic review and meta-analysis;Garassino;Anticancer Res,2009
3. Erlotinib in previously treated non-small-cell lung cancer;Shepherd;N Engl J Med,2005
4. Gefitinib in advanced non-small cell lung cancer: does it deserve a second chance?;Stinchcombe;Oncologist,2008
Cited by
689 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献